Effect of the growth hormone-secreting tumor StW5 on pituitary and adrenal gland function in rats.
A growth hormone-secreting tumor (StW5 was implanted into male rats and resulted in a tripling of adrenal weight concomitant with a 30% decrement in pituitary weight. Plasma concentrations of corticosterone in tumor-bearing (TB) rats were significantly elevated at rest or after ACTH injections or the stress of either anesthesia. The rise in plasma concentrations of corticosterone was due mainly to the large increment in adrenal size although a significant increase in adrenal responsiveness to ACTH was demonstrated in vitro. In addition, plasma corticosterone concentrations were higher in TB rats despite both a doubling of the blood volume and a 50% increase in liver capacity to metabolize corticosterone. Pituitary ACTH content was significantly lower in TB rats, but these pituitary glands could still release near-normal quantities of ACTH as shown both by in vitro incubations and adrenal corticosterone output following ether stress.
D000302:Adrenal Cortex / Q000378:metabolism* / Q000473:pathology; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D003345:Corticosterone / Q000097:blood; D005260:Female; D013006:Growth Hormone / Q000378:metabolism*; D008297:Male; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000378:metabolism*; D009929:Organ Size; D010902:Pituitary Gland / Q000378:metabolism* / Q000473:pathology; D011388:Prolactin / Q000494:pharmacology; D051381:Rats; D014184:Transplantation, Homologous
D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D013006:Growth Hormone; D003345:Corticosterone